Le Lézard
Classified in: Health
Subjects: PER, MAT

California Cryobank Welcomes Geoffrey Crouse to Board of Directors


LOS ANGELES, March 22, 2018 /PRNewswire/ -- California Cryobank (CCB), the worldwide leader in frozen donor sperm and donor egg banking, announced today Geoffrey Crouse is joining the company's Board of Directors. Crouse adds a wealth of experience and expertise to CCB's rapidly growing Stem Cell Division, which features FamilyCord, one of the country's leading private cord blood and cord tissue banks.

California Cryobank is the nation's leading frozen sperm and egg donor bank. (PRNewsfoto/Donor Egg Bank USA, a Californi)

"We are pleased to have Geoff join the CCB Board," said CEO, Richard Jennings. "His deep professional background and his commitment to life sciences will bring insightful perspectives to our Board."

"I am delighted to join the board and look forward to working with the talented management team as California Cryobank continues to build their newborn stem cell banking platform," Crouse said.

"Geoff is an extremely well-respected leader in the stem cell industry who will add a valuable dimension to our Board and to our rapidly growing FamilyCord business," added Chief Operating Officer, Pamela Richardson.

Crouse is the CEO of Syneron Candela, and previously served as CEO of CBR (Cord Blood Registry) from 2012-2015. Prior to CBR, he served as Chief Operating Officer at Immucor, a publicly traded global in vitro diagnostics company. Prior to Immucor, he served as vice president of the life sciences business at Millipore Corporation, a NYSE-traded provider of technologies, tools and services for the global life science industry.

About California Cryobank

For over 40 years, California Cryobank has helped to create and protect families around the world through frozen donor sperm and frozen donor egg services, reproductive tissue storage, and cord blood banking through FamilyCord. Operating throughout the United States, Europe, Latin America, Australia, and Asia, CCB is registered with the FDA, accredited by the AATB and AABB, and licensed by the states of California and New York. Cryobank is a portfolio company of two healthcare-focused private investment firms, Longitude Capital and NovaQuest Capital Management.

Contact: Scott Brown, 310-496-5681, [email protected]

 

SOURCE California Cryobank


These press releases may also interest you

at 18:24
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...

at 17:55
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....

at 17:43
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...

at 17:31
DelveInsight's Urine Output Monitoring Systems Market Insights report provides the current and forecast market analysis, individual leading urine output monitoring systems companies' market...

at 17:00
Enghouse Video, a global leader in cutting-edge video technology solutions, today announced its partnership with SONIFI Health, enhancing virtual care in hospital settings. SONIFI Health is a leading U.S. healthcare technology company based in Sioux...

at 17:00
A record 3,618 graduating students and physicians matched to residency training programs in Canada in this year's R-1 Main Residency Match (R-1 match), the Canadian Resident Matching Service (CaRMS) announced today....



News published on and distributed by: